These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20398592)

  • 1. Transforming strategies to provide access to care.
    Jacobson IM; Wang S; Edlin BR; Smith VK; Chow EA
    J Fam Pract; 2010 Apr; 59(4 Suppl):S59-64. PubMed ID: 20398592
    [No Abstract]   [Full Text] [Related]  

  • 2. Transforming strategies for the prevention of chronic HBV and HCV infections.
    Ward JW; Hu DJ; Alter MJ; Kanwal F; Taylor C; Block JM; Caballero JB; Chase D; Saly M; Sandt L; Swan T
    J Fam Pract; 2010 Apr; 59(4 Suppl):S23-8. PubMed ID: 20398587
    [No Abstract]   [Full Text] [Related]  

  • 3. Transforming the current infrastructure for combating HBV and HCV infections.
    Kim WR; Ward JW; Cheever LW; Dan C; Dee L; Zola J
    J Fam Pract; 2010 Apr; 59(4 Suppl):S65-70. PubMed ID: 20398593
    [No Abstract]   [Full Text] [Related]  

  • 4. Reports from today's health care environment on the implementation of screening, diagnosis, and treatment recommendations.
    Kim WR; Valdiserri RO; Wright LN; Manos MM; Do ST
    J Fam Pract; 2010 Apr; 59(4 Suppl):S43-50. PubMed ID: 20398590
    [No Abstract]   [Full Text] [Related]  

  • 5. Recommendations for prevention, screening, and diagnosis of HBV and HCV infections.
    Peters MG; Weinbaum C; Tan L; Baine WB; Dienstag JL; Liang TJ; So S
    J Fam Pract; 2010 Apr; 59(4 Suppl):S29-35. PubMed ID: 20398588
    [No Abstract]   [Full Text] [Related]  

  • 6. A National Strategy for the Elimination of Viral Hepatitis Emphasizes Prevention, Screening, and Universal Treatment of Hepatitis C.
    Buckley GJ; Strom BL
    Ann Intern Med; 2017 Jun; 166(12):895-896. PubMed ID: 28384754
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccinating adolescents in high-risk settings: lessons learned from experiences with hepatitis B vaccine.
    Sneller VP; Fishbein DB; Weinbaum CM; Lombard A; Murray P; McLaurin JA; Friedman L;
    Pediatrics; 2008 Jan; 121 Suppl 1():S55-62. PubMed ID: 18174322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the viral hepatitis problem.
    Lok AS; Kim WR; El-Serag HB; Maddrey WC
    J Fam Pract; 2010 Apr; 59(4 Suppl):S11-6. PubMed ID: 20398585
    [No Abstract]   [Full Text] [Related]  

  • 9. Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease.
    El-Serag H; McGlynn KA; Graham GN; So S; Howell CD; Fang T; Anderson JT; Thiel TK
    J Fam Pract; 2010 Apr; 59(4 Suppl):S37-42. PubMed ID: 20398589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hepatitis C in the Hispanic/Latino population living in the United States: a literature review.
    Blessman DJ
    Gastroenterol Nurs; 2008; 31(1):17-25; quiz 26-7. PubMed ID: 18300820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
    Giannousis IP; Papatheodoridis GV; Deutsch MJ; Manolakopoulos SG; Manesis EK; Koskinas JS; Archimandritis AJ
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):172-9. PubMed ID: 19738477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dawn of a new era: transforming our domestic response to hepatitis B & C.
    El-Serag H; Lok AS; Thomas DL
    Gastroenterology; 2010 Apr; 138(4):1225-30, 1230.e1-3. PubMed ID: 20176024
    [No Abstract]   [Full Text] [Related]  

  • 13. Public health management of perinatal hepatitis B virus.
    Libbus MK; Phillips LM
    Public Health Nurs; 2009; 26(4):353-61. PubMed ID: 19573214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Institute of Medicine report on viral hepatitis: a call to action.
    Sanyal AJ;
    Hepatology; 2010 Mar; 51(3):727-8. PubMed ID: 20198626
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical care of patients with chronic hepatitis B].
    Marschall T; Prüfer-Krämer L; Krämer A
    MMW Fortschr Med; 2008 Sep; 150 Suppl 3():105-11. PubMed ID: 19025208
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of chronic hepatitis B: the Indian perspective.
    Acharya SK
    Trop Gastroenterol; 2005; 26(4):171-2. PubMed ID: 16737044
    [No Abstract]   [Full Text] [Related]  

  • 17. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
    Kemp R; Miller J; Lungley S; Baker M
    N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention and treatment of hepatitis C in illicit drug users].
    Sakoman S
    Acta Med Croatica; 2009 Dec; 63(5):437-42. PubMed ID: 20198904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community approaches to women's health: delivering preconception care in a Community Health Center model.
    Wilensky S; Proser M
    Womens Health Issues; 2008; 18(6 Suppl):S52-60. PubMed ID: 18948019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.